• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.

作者信息

Miya A, Yamamoto M, Morimoto H, Tanaka N, Shin E, Karakawa K, Toyoshima K, Ishizaka Y, Mori T, Takai S

机构信息

Department of Surgery II, Osaka University Medical School, Japan.

出版信息

Henry Ford Hosp Med J. 1992;40(3-4):215-9.

PMID:1362408
Abstract

We studied the expression of the ret proto-oncogene (proto-ret) in human medullary thyroid carcinomas (MTCs) and pheochromocytomas of multiple endocrine neoplasia type 2A (MEN 2A) by Northern blot analysis. Expression of the normal-sized transcripts was detected in all 12 MTCs and in 6 of 8 pheochromocytomas. In situ localization of proto-ret mRNA revealed that the signal was confined to the cytoplasm of MTC cells. By Southern blot analysis neither amplification nor gross genetic changes of proto-ret were found in the tumors. Although no transcripts were detected in the normal portion of the thyroid from one MEN 2A patient, faint signals were detected in normal adrenal glands by Northern blot analysis, probably due to minor populations of C-cells and chromaffin cells in specimens from which MTC and pheochromocytoma might later develop. Proto-ret may play an important role in differentiation of a specific cell lineage from neuroectoderm, and it may be involved in development of MEN 2A tumors.

摘要

相似文献

1
Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.
Henry Ford Hosp Med J. 1992;40(3-4):215-9.
2
Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.1995年鲁道夫·魏尔啸奖。RET原癌基因突变分析在2型多发性内分泌腺瘤病(MEN 2)基因携带者诊断以及散发性和家族性甲状腺髓样癌与嗜铬细胞瘤鉴别中的作用
Verh Dtsch Ges Pathol. 1995;79:L-LV.
3
The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.原癌基因ret在人类嗜铬细胞瘤和甲状腺髓样癌中持续表达。
Oncogene. 1990 Oct;5(10):1595-8.
4
Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.2B型多发性内分泌腺瘤及相关散发性肿瘤中RET原癌基因酪氨酸激酶结构域内的点突变。
Hum Mol Genet. 1994 Feb;3(2):237-41. doi: 10.1093/hmg/3.2.237.
5
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.2A型多发性内分泌腺瘤病中RET原癌基因的种系突变。
Nature. 1993 Jun 3;363(6428):458-60. doi: 10.1038/363458a0.
6
[Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].通过检测RET原癌基因突变携带者对2型多发性内分泌肿瘤(MEN 2)进行早期诊断
Medicina (B Aires). 1998;58(2):179-84.
7
Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.2A型多发性内分泌腺瘤病,甲状腺髓样癌和嗜铬细胞瘤存在相同的体细胞突变,而RET原癌基因相应位点无胚系突变。
Intern Med. 1999 Feb;38(2):145-9. doi: 10.2169/internalmedicine.38.145.
8
Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.甲状腺髓样癌和嗜铬细胞瘤中c-mos原癌基因及内皮素B受体基因的突变分析
Br J Cancer. 1996 Aug;74(3):339-41. doi: 10.1038/bjc.1996.363.
9
Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A.
J Clin Endocrinol Metab. 1994 Aug;79(2):590-4. doi: 10.1210/jcem.79.2.7913936.
10
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.RET原癌基因的突变与2A型多发性内分泌腺瘤病和家族性甲状腺髓样癌相关。
Hum Mol Genet. 1993 Jul;2(7):851-6. doi: 10.1093/hmg/2.7.851.

引用本文的文献

1
TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.TMEM127 通过促进 RET 泛素化、定位和降解来抑制肿瘤的发展。
Cell Rep. 2023 Sep 26;42(9):113070. doi: 10.1016/j.celrep.2023.113070. Epub 2023 Sep 1.
2
Molecular Diagnosis of Multiple Endocrine Neoplasia (MEN) in Paraffin-Embedded Specimens.石蜡包埋标本中多内分泌腺瘤病(MEN)的分子诊断
Endocr Pathol. 1995 Winter;6(4):267-278. doi: 10.1007/BF02738727.
3
No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma.
在散发性和遗传性神经母细胞瘤中,RET突变扫描未发现突变。
Hum Genet. 1996 Mar;97(3):362-4. doi: 10.1007/BF02185773.
4
Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.通过非放射性单链构象多态性分析和直接测序检测石蜡包埋嗜铬细胞瘤标本中的RET原癌基因点突变。
Am J Pathol. 1994 Oct;145(4):922-9.
5
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B.RET原癌基因酪氨酸激酶催化结构域中的单个错义突变与2B型多发性内分泌肿瘤相关。
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1579-83. doi: 10.1073/pnas.91.4.1579.
6
Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.2型多发性内分泌腺瘤病家族的症状前基因筛查
J Mol Med (Berl). 1995 May;73(5):229-33. doi: 10.1007/BF00189922.